Edwards Lifesciences (EW) stock: key figures, P/E, revenue and dividend
Health Care · Health Care Equipment · United States · ISIN US28176E1082
Edwards Lifesciences financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 6.07 bn USD |
| Gross profit | 4.73 bn USD |
| Operating income | 1.26 bn USD |
| EBIT | 1.14 bn USD |
| Net income | 1.07 bn USD |
| Diluted EPS – continuing operations | 1.83 USD |
Full history since 1999, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Edwards Lifesciences
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
More stocks
- Ciena (CIEN)
- Vistra Corp. (VST)
- Ambev SA ADR (ABEV)
- Endesa SA (ELE.MC)
- Public Storage (PSA)
- E.ON (EOAN.DE)
- Workday, Inc. (WDAY)
- Siemens Healthineers (SHL.DE)
- China Molybdenum Co Ltd Class A (603993.SS)
- Delta Air Lines (DAL)
- Marubeni Corp (8002.T)
- People's Insurance of China Ltd (601319.SS)
Not investment advice. All data without warranty, price as of 14.10.2026. Details in the risk notice.